{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:47:37Z","timestamp":1759333657117,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jaad.2017.06.156","type":"journal-article","created":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T00:50:23Z","timestamp":1510361423000},"page":"1185-1187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Circumventing iPLEDGE: Circumventing ethical responsibility?"],"prefix":"10.1016","volume":"77","author":[{"given":"Kachiu C.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Bercovitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2017.06.156_bib1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3109\/15563650.2012.739287","article-title":"Pregnancy outcomes and factors associated with voluntary pregnancy termination in women who had been treated for acne with isotretinoin","volume":"50","author":"Yook","year":"2012","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.jaad.2017.06.156_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0190-9622(92)70088-W","article-title":"Epidemiology of isotretinoin exposure during pregnancy","volume":"26","author":"Dai","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.06.156_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/pds.3565","article-title":"Assessing the availability of the teratogenic drug isotretinoin outside the pregnancy prevention programme: a survey of e-pharmacies","volume":"23","author":"Lagan","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaad.2017.06.156_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1517\/14740338.2013.745850","article-title":"Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study","volume":"12","author":"Crijns","year":"2013","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jaad.2017.06.156_bib5","series-title":"Dermatoethics","first-page":"19","article-title":"Autonomy, isotretinoin, and iPLEDGE\u00ae: the ethics of burdensome regulation and use of teratogenic medication","author":"Bloom","year":"2012"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217320595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217320595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:45:28Z","timestamp":1759272328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962217320595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0190962217320595"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.06.156","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circumventing iPLEDGE: Circumventing ethical responsibility?","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.06.156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}